Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target

Dec.08.2022
Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target
Sweden achieves smoking rate of 5.6%, becoming the only European country to reach EU's no smoking goal ahead of schedule.

Swedish authorities have officially confirmed that the smoking rate in Sweden has now decreased to 5.6%. This makes Sweden the only European country to be on track to achieving the EU's goal of becoming smoke-free, achieving this target 18 years ahead of the 2040 deadline.


At an event organized by the Stockholm Snus Nicotine Committee, participants evaluated Sweden's incredible achievements and leadership in the fight against smoking. The country is on track to become the world's first to be defined as "smoke-free" and have a smoking population of less than 5%.


Since the 1980s, Sweden has achieved a remarkable feat unmatched by any other country in the world, reducing its smoking rate from 35% to less than 6%. The country now boasts the second lowest smoking rate in Europe, which is only half that of the next lowest country. In contrast, the average smoking rate in the EU is around 23%, which is four times higher than Sweden's. Notably, Europe also has the lowest tobacco-related death rate in the world.


On November 30, 2022, a group of leading public health experts, consumer advocates, and harm reduction professionals celebrated this achievement in Stockholm and once again called on policymakers around the world to ensure the availability of less harmful smoking alternatives as aids for quitting smoking.


Delon Human, President and Stockholm event organizer of Health Diplomats, stated during the event that if all 1.1 billion smokers worldwide were to switch to a less harmful nicotine replacement product, it could prevent disease and save millions of lives globally. Sweden has found a solution for smokers and we must work together to follow their example and save lives around the world.


This incredible success story sheds light on Sweden's secret to success, where the key factor is an open-minded attitude towards less harmful alternatives to smoking. While snus has long been at the forefront of harm reduction efforts, in recent years, nicotine pouches and e-cigarettes have become another valuable tool for Swedish smokers looking to quit.


Sweden's gradual harm reduction approach differs significantly from the measures proposed by the International Tobacco Control Organization. Advocates for harm reduction in the EU have been pushing for reductions in harm to be included in cancer prevention plans. Despite the fact that the Tobacco Control Framework Convention recognizes harm reduction as a viable option, the World Health Organization continues to refuse to acknowledge its benefits.


Professor Karl Fagerström stated during the event, "Sweden's upcoming presidency of the European Union is a great opportunity to share the country's successful stories, which accounts for 5% of the EU, with other member countries. We hope that Sweden will generously share this knowledge with other nations.


Speakers at the conference emphasized the need for evidence-based and comprehensive tobacco control policies. Therefore, it is imperative to implement the concept of reducing tobacco harm on a broader level to support smoking cessation.


Ensuring that the smoking alternatives with lower health risks are inexpensive, accessible, and easy to use, is a crucial prerequisite for Sweden's success in replicating it in other countries.


The Nicotine Oral Committee is a global nonprofit organization dedicated to assisting governments, health officials, and the public in building knowledge about nicotine oral products, challenging unfounded biases and stereotypes. The organization deals with political, scientific, consumer matters, and related product innovations. Their views are independent of any brand/manufacturer and are tailored to the individual and population health needs of adult smokers.


2FIRSTS will continue to follow and report on this topic. Updates will be available on the 2FIRSTS app. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

German Bundestag Passes Tobacco Tax Hikes: Vape Liquid Duty to Reach €0.44/ml, Heated Tobacco Taxes to Rise and Cigarettes Seen Near €12 a Pack
German Bundestag Passes Tobacco Tax Hikes: Vape Liquid Duty to Reach €0.44/ml, Heated Tobacco Taxes to Rise and Cigarettes Seen Near €12 a Pack
Germany's Bundestag passed amendments to the Tobacco Tax Act on October 15, 2026, setting out annual excise tax increases from 2027 through 2030 for e-cigarette liquids, heated tobacco, cigarettes and other tobacco products. Under the Finance Committee's amended bill, duty on qualifying e-liquids will rise from €0.32/ml in 2026 to €0.44/ml in 2030, an increase of 37.5%. Heated tobacco will retain its tax calculation based on 80% of the corresponding cigarette excise duty. The average price of a 20-cigarette pack is projected to approach €12 by 2030, with some brands potentially reaching €14. The legislation is projected to generate approximately €11.8 billion in additional tax revenue over four years and remains subject to further legislative procedures.
Regulations
Oct.19
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China's vape-related exports rose 4.5% year over year to $2.86 billion in the third quarter of 2026, led by stronger shipments to the United Kingdom as exports to the United States declined. UK-bound shipments increased 21.6%, adding $81.9 million, while US exports fell 5.2%, or $53.6 million. Growth weakened through the quarter, with September exports down 6.3% globally and 37.8% to the US. Nicotine-containing vape products accounted for more than 82% of the quarterly net increase, while device exports were nearly flat. Nine-month exports totaled $7.82 billion, up 4.0%.
DATA
Oct.26
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives